Mastriano Addresses New mRNA Vaccine in Pork Supply

HARRISBURG – Sen. Doug Mastriano (R-33) today provided the following statement regarding “Sequivity,” an RNA-based vaccine developed by Merck Animal Health that recently became commercially available, marking a significant development in the pork industry. With its newfound accessibility, there’s a possibility that pork products may now be treated with this vaccine.

“Injection of gene therapy into the food supply would result in Pennsylvanians unknowingly and unwillingly consuming gene-altering mRNA technology,” Mastriano said. “This is why I introduced Senate Bill 883 to clearly state that gene therapy products are banned from being integrated into any part of the food supply in the commonwealth.”

Media contact: Josh Herman

Back to Top